Dr. Lal PathLabs Limited
NSE:LALPATHLAB.NS
3312.7 (INR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 22,266 | 20,169 | 20,872.79 | 15,812.66 | 13,303.57 | 12,034.18 | 10,569.18 | 9,123.83 | 7,913.178 | 6,595.9 | 5,579.47 | 4,516.61 | 3,422.07 | 2,372.67 |
| Cost of Revenue
| 13,325 | 4,472 | 7,867.92 | 3,972.61 | 2,987.04 | 2,623.51 | 2,260.26 | 1,970.777 | 1,729.224 | 1,391.58 | 1,176.6 | 972.99 | 761.66 | 608.68 |
| Gross Profit
| 8,941 | 15,697 | 13,004.87 | 11,840.05 | 10,316.53 | 9,410.67 | 8,308.92 | 7,153.053 | 6,183.955 | 5,204.32 | 4,402.87 | 3,543.62 | 2,660.41 | 1,763.99 |
| Gross Profit Ratio
| 0.402 | 0.778 | 0.623 | 0.749 | 0.775 | 0.782 | 0.786 | 0.784 | 0.781 | 0.789 | 0.789 | 0.785 | 0.777 | 0.743 |
| Reseach & Development Expenses
| 38.79 | 36 | 33.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0.985 | 1.34 | 1.34 | 0 | 0 |
| General & Administrative Expenses
| 3,130 | 2,820.34 | 1,310.22 | 871.67 | 862.29 | 822.05 | 688.87 | 1,586.432 | 1,396.633 | 1,157.57 | 1,015.64 | 811.24 | 634.17 | 395.22 |
| Selling & Marketing Expenses
| 1,154 | 507.8 | 367.64 | 307.21 | 341.54 | 352.68 | 337.87 | 252.221 | 190.849 | 182.02 | 172.24 | 152.55 | 120.59 | 74.94 |
| SG&A
| 4,284 | 3,613.57 | 1,677.86 | 1,178.88 | 1,203.83 | 1,174.73 | 1,026.74 | 1,838.653 | 1,587.482 | 1,339.59 | 1,187.88 | 963.79 | 754.76 | 470.16 |
| Other Expenses
| -2,438 | -2,403 | 2.69 | -2,026.23 | -1,726.91 | -1,504.18 | -1,272.58 | 6.955 | 6.122 | 1.08 | 3.61 | 1.72 | 3.86 | 3.42 |
| Operating Expenses
| 4,284 | 9,480 | 8,466.06 | 6,197.03 | 5,817.99 | 5,285.44 | 4,682.44 | 5,058.619 | 4,361.143 | 3,916.46 | 3,265.37 | 2,759.23 | 1,981.02 | 1,321.82 |
| Operating Income
| 4,657 | 3,401.53 | 4,547.08 | 3,597.8 | 2,709.09 | 2,557.42 | 3,626.48 | 2,094.434 | 1,822.812 | 1,287.86 | 1,137.5 | 784.39 | 679.39 | 442.17 |
| Operating Income Ratio
| 0.209 | 0.169 | 0.218 | 0.228 | 0.204 | 0.213 | 0.343 | 0.23 | 0.23 | 0.195 | 0.204 | 0.174 | 0.199 | 0.186 |
| Total Other Income Expenses Net
| 398 | 36.74 | 202.74 | 346.29 | 395.94 | 448.06 | -1,013.33 | 238.545 | 184.347 | 109.12 | 54.56 | 17.62 | -15.17 | 5.14 |
| Income Before Tax
| 5,055 | 3,439 | 4,749.82 | 3,944.09 | 3,105.03 | 3,005.48 | 2,613.15 | 2,332.979 | 2,007.158 | 1,396.98 | 1,192.06 | 802.01 | 664.22 | 447.31 |
| Income Before Tax Ratio
| 0.227 | 0.171 | 0.228 | 0.249 | 0.233 | 0.25 | 0.247 | 0.256 | 0.254 | 0.212 | 0.214 | 0.178 | 0.194 | 0.189 |
| Income Tax Expense
| 1,432 | 1,028 | 1,246.91 | 979.3 | 829.16 | 1,000.81 | 895.3 | 781.035 | 674.869 | 447.01 | 389.43 | 245.54 | 212.55 | 151.85 |
| Net Income
| 3,577.35 | 2,388.48 | 3,448 | 2,916.21 | 2,259.41 | 1,991.8 | 1,707.65 | 1,542.055 | 1,321.897 | 942.44 | 795.87 | 551.32 | 447.14 | 291.2 |
| Net Income Ratio
| 0.161 | 0.118 | 0.165 | 0.184 | 0.17 | 0.166 | 0.162 | 0.169 | 0.167 | 0.143 | 0.143 | 0.122 | 0.131 | 0.123 |
| EPS
| 43.05 | 28.82 | 41.7 | 35.33 | 27.42 | 24.19 | 20.82 | 19.02 | 16.09 | 16.79 | 9.63 | 6.67 | 5.41 | 3.52 |
| EPS Diluted
| 42.98 | 28.74 | 41.57 | 35.25 | 27.37 | 24.15 | 20.82 | 18.95 | 15.98 | 11.65 | 9.63 | 6.67 | 5.41 | 3.52 |
| EBITDA
| 6,093 | 5,316 | 6,095.18 | 4,827.52 | 3,955.47 | 3,409.87 | 2,985.3 | 2,621.149 | 2,296.662 | 1,688.57 | 1,483.68 | 1,016.87 | 896.79 | 599.68 |
| EBITDA Ratio
| 0.274 | 0.264 | 0.292 | 0.305 | 0.297 | 0.283 | 0.282 | 0.287 | 0.29 | 0.256 | 0.266 | 0.225 | 0.262 | 0.253 |